News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Patent News
IntelGenx Corp. Announces Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/25/2014
Arena Pharmaceuticals, Inc. (ARNA) Issued Composition Of Matter Patent By United States Patent And Trademark Office For Ralinepag And Related Compounds 11/25/2014
Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property 11/25/2014
Supernus Pharmaceuticals (SUPN) Files Lawsuit Against Zydus Pharmaceuticals (USA) Inc. In U.S. Court For Infringement Of Patents Covering Its Antiepileptic Drug, Trokendi XR 11/25/2014
Xenetic Biosciences Provides Update On Substantial Patent Grants And Allowances In U.S. and Worldwide 11/25/2014
Mylan Inc. (MYL) Confirms First-To-File Patent Challenge Relating To BREVIBLOC 11/25/2014
Catalyst Pharmaceuticals (CPRX) Announces Notice Of Allowance Of U.S. Patent Application For The Reduction Or Elimination Of Visual Field Defects By Treating Patients With CPP-115 11/24/2014
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Fifth U.S. Patent Protecting Trokendi XR(R) 11/24/2014
Forward Pharma (FWP) Receives Issue Notification For Erosion Matrix Patent In The U.S. 11/24/2014
ChromaDex, Inc. Announces Two Patent Issuances For Novel Ingredient, Pterostilbene 11/24/2014
Orexigen Therapeutics, Inc. (OREX) Announces Allowance Of New U.S. Patent For Contrave (Naltrexone Hcl / Bupropion Hcl Extended Release) 11/21/2014
Ebola Vaccine Running Into Patent Cover In Canada? 11/21/2014
Highland Therapeutics Receives Second Notice Of Allowance For Patent On Lead Product 11/20/2014
Seegene, Inc. Receives US Patent For TOCE Technology 11/19/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For Tanibirumab, An Anti-VEGFR2/KDR Mab With Pharmabcine 11/18/2014
Aphios Granted United States Patent For Nanotechnology Co-Encapsulation Of Combination Drugs & Drug Products 11/18/2014
OXiGENE (OXGN) Announces Issuance Of European Patent for OXi4503 In Acute Myeloid Leukemia And Other Myeloid Malignancies 11/17/2014
AbbVie (ABBV) Uses Patents To Ambush Gilead Sciences, Inc. (GILD) 11/14/2014
Regeneus (RGS.AX) Acne Treatment Patent Granted 11/14/2014
BioLargo, Inc. (BLGO.PK) Issued Patent For Its Platform Of Liquid And Hydrogel Iodine Technologies 11/13/2014
Highland Therapeutics Receives Notice Of Allowance For Patent On Lead Product 11/13/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Two New U.S. Patents Relating To Topical Tetracycline Compositions 11/13/2014
Horizon Pharma plc.  (HZNP) Announces Favorable Markman Ruling in RAYOS® (prednisone) Delayed-Release Tablets Patent Infringement Litigation 11/12/2014
Aegis Therapeutics, LLC Awarded Patent For Intranasal Administration Of Active Agents To The Central Nervous System 11/12/2014
New U.S. Patent Issued To Dyadic International, Inc. 11/12/2014
Pluristem Therapeutics (PSTI) Granted Patents In Australia And New Zealand For Use Of Placental Cells In The Treatment Of Multiple Indications 11/12/2014
Genovis Sues U.S. Company For Patent Infringement 11/11/2014
Matinas BioPharma Receives Notice Of Allowance Of U.S. Patent For MAT9001 11/10/2014
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Fourth U.S. Patent Protecting Trokendi XR® 11/7/2014
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Receives U.S. Patent Claiming Alternative Methods to Manufacture Pancreatic Progenitor Cells In Vitro 11/6/2014
PuriCore Granted Two U.S. Patents 11/5/2014
Reflect Scientific, Inc. Files Patent For Low Temperature Freezer Technology 11/4/2014
U.S. Patent Office Significantly Extends The Term Of Three RegenRx Patents 11/3/2014
OncoMed Pharmaceuticals, Inc. (OMED) Granted Anti-DLL4/Anti-VEGF Bispecific Antibody Patent In The U.S. 11/3/2014
AmnioLife Files U.S. Patent Application 10/31/2014
Cipla Ltd. Asks Government To Revoke Five Patents Held By Novartis AG (NVS) 10/30/2014
When Will Biosimilars Impact The U.S. Market? 10/30/2014
Levolta Pharmaceuticals Receives U.S. Patent For Novel Investigational Therapy For Controlling Osteoarthritis 10/30/2014
The Medicines Company (MDCO) Wins Favorable Judgment In Angiomax® (Bivalirudin) Patent Litigation 10/28/2014
RenovoRx Announces The U.S. Patent And Trademark Office Issuance Of Patent 10/28/2014
Curis, Inc. (CRIS) Announces Allowance Of U.S. Patent Covering Compounds Targeting HDAC And PI3K Activities In A Single Molecule 10/28/2014
Pharmalink AB Extends Patent Protection For Nefecon® Treatment For Renal Disease 10/27/2014
New AbbVie (ABBV) Head Blasts Canada’s Patent Laws On Drugs 10/24/2014
Epizyme (EPZM) Announces Notices Of Allowance For US Patent Applications Covering PRMT5 Inhibitors And Methods Of Cancer Treatment With PRMT5 Inhibitors 10/23/2014
Pozen, Inc. (POZN) Announces Receipt Of Three Patents From The United States Patent And Trademark Office 10/23/2014
Actavis (ACT) Confirms Appeals Court Upholds Lo Loestrin® Fe Patent 10/23/2014
Synthetic Biologics, Inc. (SYN) Announces Allowance Of Key U.S. Composition Of Matter Patent For C. Difficile Program 10/22/2014
MiMedx Provides Update On Outstanding Patent Litigation 10/21/2014
Reflect Scientific, Inc. Continues To Solidify Patent Position In Cryogenic Technologies 10/21/2014
ERYtech Pharma Announces Granting Of New Patent In The United States 10/21/2014
NeuroSigma, Inc. Receives Notice of Allowance Of U.S. Patent Application 10/21/2014
Lpath, Inc. (LPTN) Granted Key European Patent Related To iSONEP And ASONEP Programs 10/20/2014
Amgen (AMGN) Files Lawsuit Against Sanofi (SAN.PA) And Regeneron (REGN) For Patent Infringement 10/17/2014
Noven Pharmaceuticals Inc. Files Patent Infringement Lawsuit Against Actavis (ACT) 10/17/2014
AcelRx Pharmaceuticals (ACRX) Provides Update On Its Patent Portfolio For Zalviso™ And Its Proprietary Platform Technologies 10/16/2014
Largest Biotech IPO Yet Could Be Derailed By Forward Pharma (FWP), Biogen Idec (BIIB) Patent Fight 10/15/2014
Orgenesis Receives Patent For Potential Cure For Type 1 Diabetes 10/15/2014
Mariel Therapeutics Announces Issuance Of Two Key U.S. Patents For The Use Of Bone Morphogenetic Protein -7 (BMP-7) In Osteoarthritis (OA) And Chronic Kidney Disease (CKD) 10/15/2014
Mission Pharmacal Company Settles Patent Infringement Suit With Virtus Pharmaceuticals 10/14/2014
Galena Biopharma  (GALE) Receives Notice Of Allowance Of Improvement Patent For Neuvax® (nelipepimut-S) In Japan 10/14/2014
Prima Biomed (PRR.AX) Announces Immutep S.A.'s IMP321 Patent Application Receives Australian Notice Of Allowance 10/14/2014
BioAtla Receives Broad Patent For Antibody Development 10/14/2014
Apricus Biosciences (APRI) Announces Notice Of Allowance Of U.S. Patent Application For Rayva™ 10/13/2014
BTG plc (BTG.L) Reaches Settlement Regarding CroFab® Patent Litigation 10/10/2014
R-Tech Ueno: Settlement Agreement That Resolves Patent Litigation In U.S. Related To AMITIZA® And Company Receives Additional Paragraph IV Notice 10/10/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Settlement Agreement That Resolves Patent Litigation In U.S. Related To AMITIZA 10/10/2014
Roche (RHHBY) Acquires Rights To Technology And Patent Applications From Abvitro To Support Next-Generation Sequencing Pipeline 10/9/2014
Histogen, Inc.’s Composition For Oncology Treatments Receives US Patent 10/8/2014
Pivotal Therapeutics Inc. Receives Notification Of Allowance For U.S. Patent Related To Combination VASCAZEN® And Cholesterol Absorption Inhibitor 10/8/2014
Bristol-Myers Squibb Company (BMY) Statement On Sustiva (Efavirenz) In The U.S. 10/8/2014
MediGene AG (MDGEF.PK) Receives Patent For TCR-Modified T Cell Immunotherapy In Australia 10/8/2014
Aciex Therapeutics Announces Issuance Of Separate U.S. Patents Covering Two Leading Product Candidates 10/8/2014
Neos Therapeutics Announces Issuance Of Key Patent Covering Its Extended Release Oral Disintegrating Tablet (XR-ODT) Platform Technology 10/8/2014
Aphios Granted United States Patent For Nanotechnology Formulation Of Poorly Soluble Drugs 10/8/2014
Galena Biopharma  (GALE) Announces Notice Of Allowance Of U.S. Patent Application For Neuvax™ (Nelipepimut-S) Combination 10/8/2014
Vical Incorporated (VICL) Granted Six U.S. Patents For HSV-2 Vaccines 10/8/2014
IRIDEX Corporation (IRIX) Granted U.S. Patent For Disposable MicroPulse® Delivery Device For The Non-Invasive Treatment Of Glaucoma 10/7/2014
Boston Therapeutics, Inc. Files Patent Application For Novel Therapeutic Uses Of BTI-320 10/7/2014
Aegis Therapeutics, LLC Awarded 2nd Patent For Monoclonal Antibody Formulations That Avoid Oxidative Damage Due To Polysorbate Surfactants 10/7/2014
Enzo Biochem (ENZ) Awarded Patent For Novel Vectors Involving Gene Therapy Treatments For Cancer, Virus Infections And Genetic Diseases 10/7/2014
Halozyme Therapeutics, Inc. (HALO) Announces Issuance Of U.S. Patent For Companion Diagnostic For PEGPH20 10/7/2014
Pivotal Therapeutics Inc. Announces Notification Of Patent Allowance For U.S. Application 13/584,480 Related To Combination Product Of VASCAZEN® And Statin Therapy 10/7/2014
Eleven Biotherapeutics (EBIO) Granted U.S. Composition-of-Matter Patent For EBI-005 10/7/2014
Pluristem Therapeutics (PSTI) Wins Cell Therapy Patent Case In Europe; European Patent Office Confirms Validity Of Amended Claims 10/7/2014
U.S. Patent Office Institutes Inter Partes Review Brought By MonoSolRx LLC Against All Claims In Key BDSI BEMA Patent 10/6/2014
CleveXel Pharma To License Two New Oncology Patents From SATT Sud Est 10/6/2014
Horizon Pharma plc.  (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of Additional Notice Of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets 10/2/2014
TherapeuticsMD, Inc.  (TXMD) Granted Two New Patents 10/1/2014
Stemedica Cell Technologies, Inc. Secures U.S. Patent To Use Multiple Stem Cell Lines Simultaneously To Treat Ischemic Stroke 10/1/2014
Keryx Biopharmaceuticals (KERX) Announces Issuance Of A New U.S. Patent For Ferric Citrate Covering Orally Administrable Forms 10/1/2014
U.S. Patent and Trademark Office Issues Can-Fite BioPharma (CFBI) Patent For CF102 In The Treatment Of Liver Regeneration And Function Following Surgery 9/30/2014
KemPharm, Inc. Receives Patent From The USPTO For Novel Prodrug Of Hydromorphone, KP511 9/30/2014
Edge Therapeutics, Evonik Industries Granted EG-1962 Composition Of Matter Patent 9/30/2014
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Canadian Patent For Inhibition Or Reversal Of Skin Aging 9/30/2014
Opexa Pharmaceuticals, Inc. Strengthens Patent Portfolio With Expansion Into B-Cell Diseases And Announces Allowance Of 98th T-Cell Patent 9/29/2014
Actavis (ACT) Confirms Generic Butrans® Patent Challenge 9/26/2014
Regulus Therapeutics, Inc. Announces Notice Of Allowance From U.S. Patent Office Related To Microrna-103/107 Program In Metabolic Disorders 9/24/2014
iCeutica Inc. Receives Key Patent For Solumatrix Fine Particle Technology™ Platform 9/23/2014
Telormedix Granted European Patent For Vesimune 9/22/2014
Spherix (SPEX) Notified By United States Patent & Trademark Office Of New Standard Essential Patent Issued To Spherix 9/22/2014
Kymab Succeeds In Revoking Regeneron Pharmaceuticals, Inc. (REGN)’s European Patent 9/19/2014
Patent Position Of Merus' MeMo® Mouse Strengthened by Ruling of European Patent Office 9/18/2014
Biocept, Inc. (BIOC) Granted Patent In China For Its Microfluidic Channel Technology Used To Capture Circulating Tumor Cells 9/18/2014
Biostar Pharmaceuticals, Inc. (BSPM) Files A PRC Patent Application For Oleanolic Acid Injection, Its New Drug Product For Hepatitis B And Liver Cancer 9/18/2014
Salix Pharmaceuticals, Ltd. (SLXP) Secures Additional Intellectual Property Relating To Rifaximin 9/18/2014
Regen BioPharma Files Patent Application On New Therapy That Uses the "Innate" Immune System To Kill Cancer 9/17/2014
Oculus Innovative Sciences, Inc. (OCLS) Strengthens Intellectual Property Portfolio With Allowance Of Four New Patents For Microcyn® Technology 9/16/2014
Advanced Medical Isotopes Corporation Licensed Brachytherapy Seed Patent Granted 9/16/2014
Trevena, Inc. (TRVN) Granted Key U.S. Composition Of Matter Patent For TRV130 9/16/2014
Spectrum Pharmaceuticals, Inc. (SPPI) Announces Issue Of A New Patent For Beleodaq™ (Belinostat) For Injection With Patent Term Adjustment Till 2027 9/16/2014
Marina Biotech, Inc. (MRNA) Announces The Continued Worldwide Expansion Of Its Delivery Technology Intellectual Property Estate 9/15/2014
Dyax Corp. (DYAX) Announces Issuance Of Two Key U.S. Patents For DX-2930 9/15/2014
Galectin Therapeutics Announces Issuance Of U.S. Patent For GR-MD-02 In Diabetic Nephropathy 9/15/2014
Egalet Announces Issuance Of U.S. Patents Covering Guardian™ Technology And Product Candidates 9/11/2014
Lakewood-Amedex Inc. Receives Notice Of Allowance From The United States Patent and Trademark Office (USPTO) For A New Patent Covering Its nanoRNA Gene-Silencing Technology 9/11/2014
Marrone Bio Innovations Receives Patent For Use Of Chromobacterium To Control Corn Rootworm Larvae Infestation 9/11/2014
NeoStem, Inc. Announces Licensing Of Patent Portfolio From The Rockefeller University Expanding Its Cancer Immunotherapy Intellectual Property Portfolio 9/11/2014
Flexion Therapeutics (FLXN) Announces Issuance Of U.S. Composition Of Matter Patent For Lead Candidate FX006 9/9/2014
Mersana Therapeutics, Inc. Strengthens Antibody-Drug Conjugate Intellectual Property Position With Issuance Of Three Additional U.S. Patents 9/9/2014
GenSpera Receives Patent On Prodrug Targeted For Prostate Cancer 9/9/2014
Gentag, Inc.'s Disposable NFC Biomarker Patent Receives Notice Of Allowance From The European Patent Office 9/9/2014
Argos Therapeutics, Inc. (ARGS) Announces Issuance Of Arcelis® Technology Platform Patent 9/8/2014
BerGenBio AS Granted Platform Patent - Cellselect™ Platform Also Described In Peer-Reviewed Journal 9/8/2014
Alitair Pharmaceuticals Receives A U.S. Composition Of Matter Patent For Benzonatate Polacrilex 9/5/2014
Can-Fite BioPharma (CFBI) Issued Japanese Patent For CF102 In The Treatment Of Liver Regeneration And Function Following Surgery 9/5/2014
Advanced Cell Technology Announces Issuance Of Patent Covering Dendritic Cells Manufacturing From Renewable Stem Cell Sources 9/5/2014
Clearside Biomedical Announces Fourth Patent Allowance In The U.S. Related To Proprietary Microneedle Drug Delivery Methods And Devices 9/4/2014
KineMed, Inc. Receives U.S. Patent Allowance For Noscapine To Treat ALS, Parkinson’s Disease, And Diabetic Neuropathy 9/4/2014
Supernus Pharmaceuticals (SUPN) Announces Issuance of Fourth US Patent Protecting Oxtellar XR® 9/4/2014
DelMar Pharmaceuticals Receives Notice Of Allowance For Second U.S. Patent For VAL-083 9/3/2014
Orexigen Therapeutics, Inc. (OREX) Expands NB32 Intellectual Property Portfolio With New U.S. Patent 9/3/2014
Suven Life Sciences Ltd Secures (3) Product Patents For Their NCEs In South Korea, China And Canada 9/3/2014
Rexahn Pharmaceuticals, Inc. (RNN) Receives A Notice Of Allowance From The U.S. Patent And Trademark Office For A Novel Targeted Cancer Drug Delivery Platform 9/3/2014
United States Patent & Trademark Office Issues Three New Standard Essential Patents To Spherix (SPEX) 9/2/2014
United Therapeutics Corporation (UTHR) Release: District Court Decision Received In Remodulin Patent Case 8/29/2014
Cellular Dynamics International Awarded U.S. Patent Covering Automated Production Of All Human Pluripotent Stem Cells 8/29/2014
Onxeo Strengthens Beleodaq® Patent Protection In The U.S. Until 2027 8/28/2014
iBio, Inc. (IBIO) Receives European Patent Allowances For Protein Expression Technology 8/28/2014
Ryogen LLC Awarded Two U.S. Patents Directed To Hepatitis C And Diabetes 8/27/2014
Alnylam Pharmaceuticals (ALNY) Receives Notice Of Allowance From United States Patent And Trademark Office (USPTO) For New Patent Broadly Covering Rnai-Mediating, Double-Stranded Molecules Of 19 To 52 Nucleotides In Length 8/27/2014
Horizon Pharma Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets 8/27/2014
TxCell Granted Five New Patents In Major Global Territories For Core Technology And Astria Platform Since January 2014 8/27/2014
MultiCell Technologies Inc. (MCET.OB) Granted U.S. Patent Covering Therapeutics Which Fight Virus Infection And Cancer 8/25/2014
Actavis (ACT) Confirms Generic Neupro® Patent Challenge 8/25/2014
BioLineRx Ltd. Receives Notice Of Allowance For U.S. Patent On BL-7010 Covering Use Of Novel Polymer In Prevention Of Gluten Toxicity 8/21/2014
Dicerna Pharmaceuticals (DRNA) Announces The Issuance Of Multiple Patents Covering Claims For Dicer Substrate SiRNAs 8/21/2014
Alnylam Pharmaceuticals (ALNY) Receives Notice Of Allowance From United States Patent And Trademark Office (USPTO) For New Patent Broadly Covering Rnai-Mediating Double-Stranded Molecules Comprising Up To 25 Base Pairs 8/20/2014
Achillion Pharmaceuticals, Inc. (ACHN) Granted U.S. Patent For ACH-3102 And Structurally Related NS5A Inhibitors 8/20/2014
VistaGen Therapeutics, Inc. Receives Notice Of Allowance For Canadian Patent Further Expanding Stem Cell Technology Platform 8/19/2014
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent in Spain For Oral Administration Of Insulin 8/19/2014
BioBlast Pharma (ORPN) Receives Notice Of Allowance From USPTO For Its Novel Fusion Protein-Based Platform For The Treatment Of Friedrich's Ataxia 8/18/2014
Trevi Therapeutics Announces The Issuance Of Two Patents Covering The Oral Sustained Release Formulation Of Nalbuphine ER 8/14/2014
La Jolla Pharmaceutical Company (LJPC) Receives Notice Of Allowance For Additional Patent Claims Covering Modified Pectin For The Treatment Of Chronic Inflammation 8/14/2014
Access Pharmaceuticals (ACCP) Awarded Japan Patent For MuGard And ProctiGard 8/14/2014
Nodality, Inc. Expands Intellectual Property Estate, Announces U.S. Patent For Broadly Enabling Single Cell Network Profiling (SCNP) Technology Platform 8/14/2014
eAgile Awarded Patent For RFID Intelligent Packaging Breakthrough 8/12/2014
MediciNova, Inc. Receives Notice Of Allowance For New Patent Covering MN-001 And MN-002 For The Treatment Of Nonalcoholic Fatty Liver Disease 8/12/2014
EnGeneIC Pty Ltd Receives Patent From The USPTO For EDV™ Nanocell Technology 8/11/2014
Extending Patent Protections To Discover The Next Life-Saving Drugs 8/11/2014
InVivo Therapeutics Corporation (NVIV) Receives Notice Of Allowance On Patent Covering Neuro-Spinal Scaffold And Neuro-Spinal Scaffold Plus Stem Cells 8/11/2014
Mallinckrodt Pharmaceuticals (MNK) Receives Patent From U.S. Patent And Trademark Office 8/6/2014
Horizon Pharma Announces The U.S. Patent And Trademark Office Issuance Of Additional Notices Of Allowance With Claims Covering VIMOVO®(Naproxen / Esomeprazole) Delayed Release Tablets 8/6/2014
Islet Sciences Receives Notice Of Allowance For U.S. Patent Covering Novel IL-12 Inhibitors 8/6/2014
Suven Life Sciences Ltd Secures (2) Product Patents For Their Nces In Australia And Eurasia 8/6/2014
Menlo Park's TesoRx Locks In $10 Million, Secures Key Patent And Taps Renowned Urologist As Chief Medical Officer 8/5/2014
United States Patent Issued To Adamas Pharmaceuticals (ADMS) 8/5/2014
Trevena, Inc. (TRVN) Granted Key U.S. Method Of Use Patent For TRV027 8/5/2014
Galectin Therapeutics Receives U.S. Patent For GR-MD-02 Composition Of Matter 8/5/2014
Transgenomic, Inc. (TBIO) Announces Issuance Of New European Patent Covering COLD-PCR Technologies 7/31/2014
Mystic Pharmaceuticals Receives Notice Of Allowance For Novel Powder Drug Delivery Technology 7/31/2014
CDEX Inc. (CDEX) Granted Notice Of Allowance For U.S. Patent Application Covering Identification And Determination Of Chemical Substances Using Enhanced Photoemission Spectroscopy 7/31/2014
GenSpera Announces US Patent For Methods And Compositions For The Detection, Imaging And Treatment Of Cancer 7/30/2014
Ryogen LLC Awarded Two Patents Directed To Polynucleotide Sequences That Play Key Roles In Various Cancers 7/29/2014
VGTI Florida Researcher Invents Potential Breakthrough Antiviral Compounds For Prevention Of Mosquito-Borne Illnesses 7/28/2014
Advaxis, Inc. Receives Notice Of Allowance For Cancer Immunotherapies Patent In Japan 7/28/2014
Genticel Granted Five New Patents In The Us And Asia During First Half Of 2014 7/24/2014
MYOS (MYOS) Receives Notice Of Allowance Of U.S. Patent Application For Proprietary Manufacturing Methods Of Fortetropin 7/24/2014
Particle Sciences And Eyeon Therapeutics Receive Patent On Novel Dry Eye Technology 7/22/2014
U.S. Patent Office Grants McCord Research Endothelial Cell Treatment Patent 7/22/2014
Alnylam Pharmaceuticals (ALNY) Receives Notice Of Allowance From United States Patent And Trademark Office (USPTO) For New Patent Broadly Covering Conjugate-Based Delivery Of RNA Therapeutics 7/22/2014
Opko Health, Inc. Granted Patent From U.S. Patent & Trademark Office For RAYALDEE 7/22/2014
Drawbridge Pharmaceuticals Extends Phaxan™ Patent Portfolio With Divisional Patents Granted For Other Neuroactive Steroids 7/22/2014
Hepatitis C Spurs Unusual Patent Wars Among Big Drug Makers 7/21/2014
Integral Molecular, Inc. Announces Patent Allowance For Dengue Research Technology 7/18/2014
BMC To Actively Defend Against Curative In Patent Fight 7/18/2014
Agile Therapeutics, Inc. Announces Allowance Of Additional Patent Claims For Skinfusion® 7/18/2014
Columbia Laboratories, Inc. (CBRX) Expands Its Intellectual Property Portfolio Following Receipt Of U.S. Patent 7/17/2014
Prima Biomed (PRR.AX) Receives U.S. Patent Grant For CVac 7/16/2014
Arena Pharmaceuticals, Inc. (ARNA) Issued Patent For APD371 By United States Patent And Trademark Office 7/16/2014
InSite Vision (ISV) Announces The Issuance Of Broad U.S. Patent Covering Bromfenac Formulations In Durasite® 7/16/2014
Lipocine Inc. (LPCN) Announces Issuance Of U.S. Patent For LPCN 1021 7/16/2014
C4X Discovery Patent Granted In Japan 7/15/2014
Kraig Biocraft Laboratories, Inc. Announces U.S. Patent And Trademark Office Has Registered The Company's Monster Silk® Trademark 7/15/2014
BioTime (BTX) Announces Issuance Of 14 Patents In The Fields Of Regenerative Medicine, And Cancer Diagnosis And Therapy 7/14/2014
Actavis (ACT) Confirms Generic Diclegis® Patent Challenge 7/14/2014
Zogenix, Inc. (ZGNX) Announces New Patent Valid Through 2032 For DosePro® Needle-Free Delivery System 7/14/2014
Transplant Genomics Inc. Announces Exclusive License To Patent Rights Co-Owned By The Scripps Research Institute And Northwestern University 7/14/2014
Microbix Biosystems Inc. (MBXBF) Sues Novartis AG (NVS) For Infringement Of Its VIRUSMAX® Patent In Europe 7/10/2014
Rosetta Genomics Ltd. (ROSG) Receives Notice Of Allowance For U.S. Patent For The Treatment Of Ovarian Cancer 7/10/2014
Pharmalink AB's Core Patents For Nefecon® Treatment For Renal Disease Granted In United States, Europe, China And Hong Kong 7/10/2014



//-->